RA
CSLT

Royce & Associates’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Royce & Associates’s Portfolio CSLT Stock Details CSLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,356,552
Closed -$3.57M – 1034
2021
Q2 		$3.57M Sell
1,356,552
-1,766,000
-57% -$3.29M 0.02% 667
2021
Q1 		$4.71M Buy
3,122,552
+551,092
+21% +$956K 0.03% 614
2020
Q4 		$3.34M Buy
2,571,460
+192,426
+8% +$216K 0.03% 635
2020
Q3 		$2.69M Buy
2,379,034
+30,000
+1% +$33K 0.03% 623
2020
Q2 		$1.95M Buy
2,349,034
+110,000
+5% +$81.7K 0.02% 671
2020
Q1 		$1.62M Buy
2,239,034
+115,000
+5% +$128K 0.02% 641
2019
Q4 		$2.83M Buy
2,124,034
+4,637
+0.2% +$6.47K 0.03% 627
2019
Q3 		$2.99M Buy
2,119,397
+213,153
+11% +$425K 0.03% 610
2019
Q2 		$6.16M Buy
1,906,244
+381,101
+25% +$1.31M 0.06% 442
2019
Q1 		$5.72M Buy
1,525,143
+399,843
+36% +$1.27M 0.05% 477
2018
Q4 		$2.44M Buy
1,125,300
+42,240
+4% +$105K 0.02% 670
2018
Q3 		$2.92M Buy
1,083,060
+147,907
+16% +$523K 0.02% 734
2018
Q2 		$3.97M Buy
935,153
+240,578
+35% +$904K 0.03% 656
2018
Q1 		$2.54M Buy
694,575
+505,566
+267% +$1.87M 0.02% 789
2017
Q4 		$709K Sell
189,009
-11,000
-5% -$44K ﹤0.01% 1019
2017
Q3 		$860K Buy
200,009
+10,800
+6% +$44.5K 0.01% 985
2017
Q2 		$785K Sell
189,209
-274,500
-59% -$1.07M 0.01% 1007
2017
Q1 		$1.69M Buy
463,709
+329,188
+245% +$1.16M 0.01% 899
2016
Q4 		$666K Buy
134,521
+47,001
+54% +$213K ﹤0.01% 986
2016
Q3 		$364K Buy
+87,520
New +$357K ﹤0.01% 1016
2015
Q4 		– Sell
-385,600
Closed -$1.62M – 1196
2015
Q3 		$1.62M Buy
385,600
+25,000
+7% +$158K 0.01% 905
2015
Q2 		$2.94M Buy
360,600
+207,200
+135% +$1.73M 0.01% 864
2015
Q1 		$1.19M Buy
+153,400
New +$1.31M ﹤0.01% 1007

Other funds holding CSLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
VMV
Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
SCM
SCW Capital Management Dallas, Texas $44M AUM 39.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Royce & Associates's CSLT Position: Q3 2021 in Review

Royce & Associates sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q3 2021, closing a stake of 1,356,552 shares — an estimated $3.57M sold.

Royce & Associates first reported a position in CSLT in Q1 2015 and held it in 23 quarters. The position peaked at $6.16M in Q2 2019. 106 funds tracked by Wall St. Rank hold CSLT as of Q3 2021.

  • Royce & Associates reported no remaining CASTLIGHT HEALTH, INC. position as of Q3 2021 after selling out during the quarter.
  • Royce & Associates sold 1,356,552 CASTLIGHT HEALTH, INC. shares in Q3 2021, an estimated $3.57M.
  • Royce & Associates first reported a position in CASTLIGHT HEALTH, INC. in Q1 2015 and held it in 23 quarters.
  • Royce & Associates's CASTLIGHT HEALTH, INC. position peaked at $6.16M in Q2 2019.
  • 106 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q3 2021.

Based on Royce & Associates's 13F filing for Q3 2021, filed 10 Nov 2021.